2022 Cannabinoid pharmaceutical companies

Cannabinoid pharmaceutical companies are gaining popularity in the pharmaceutical industry in some countries.

Cannabinoids have numerous therapeutic applications, including the treatment of epilepsy and pain disorders, according to researchers.

Despite this, their position in the pharmaceutical industry remains ambiguous due to apparent contradictory regulations.

In North America, cannabinoids are “a complete mess from a pharmaceutical standpoint.” Despite significant pre-clinical research by the US National Institutes of Health (NIH), active pharmaceutical ingredients (APIs) are fundamentally still illegal at the federal level, despite legalization in some states.

This makes it extremely difficult to hire competent researchers to build a business or development program around a pharmaceutical pipeline. Furthermore, the prospect of transporting cannabinoids is difficult in the United States, as drivers may be able to leave some states but not enter others, making moving people, products, or ingredients across state lines difficult.

Authorities in the United States, such as the Food and Drug Administration (FDA), have recently issued several warning letters to various companies making unsubstantiated cannabidiol (CBD) claims about their products, and it appears that the market will become more tightly regulated (in comparison to Canada), with defined boundaries of use for pharmaceutical claims.

Canada is at the other end of the North American spectrum. After legalizing cannabis, the country has been able to move forward with developing therapeutic pipelines for cannabinoids with relative ease.

Drug-drug interactions with cannabinoids are currently evident, but their long-term accumulation in adipose tissues has not been thoroughly studied. The long-term effects of cannabinoids as a biologically active ingredient will be revealed in five to ten years, once data are abundant on them.

Overview of the Cannabis Pharmaceuticals Market

Cannabis-based products, also known as medical marijuana, have opened up new avenues in the pharmaceutical industry.

Small and large pharmaceutical companies have made significant investments in cannabidiol (CBD), in particular.

The inroads made by CBD and CBD-based products are undeniably daunting, riding on the wave of marijuana legalization in stages.

Because of cannabis’s game-changing potential, pharmaceutical companies have set their sights on the cannabis pharmaceuticals market.

Unsurprisingly, some pharmaceutical companies, such as Insys Therapeutics, are staunchly opposed to marijuana legalization.

A new study on the cannabis pharmaceuticals market examines the investment potential of some of the aforementioned trends and how they will shape the growth dynamics between 2020 and 2030.

Key Trends in the Cannabis Pharmaceuticals Market

The changing regulatory landscape is expected to shape the shape of the cannabis pharmaceuticals market.

However, as things begin to change, the global medicinal industry will step up its efforts to harness cannabis’s therapeutic benefits.

The cannabis pharmaceutical industry will see new vistas open up as a growing number of studies provide scientific support for CBD. This is especially true when it comes to safety and uncontested claims of safety.

Furthermore, as regulators treat various categories of cannabis-based products differently and appropriately, the risk-benefit profile of cannabis pharmaceuticals will become clearer.

The scientific rigor for evidence-based medicine will broaden the market’s potential and pave the way for research in purified cannabidiol.

The cannabis pharmaceuticals market has high hopes in two areas: reducing the opioid epidemic and treating some of the most difficult-to-treat conditions, such as some cancers. Stakeholders also recognize medical cannabis’s potential for aesthetic and medical dermatology.

Cannabinoid Pharmaceutical Companies

Here are some of the cannabinoid pharmaceutical companies operating around the world.

180 Life Sciences

Address: 3000 El Camino Real Bldg. 4, Suite 200 Palo Alto, CA 94306

Phone: (650) 507-0669

Website: Click Here

Artelo Biosciences

Address: 505 Lomas Santa Fe, Suite 160 Solana Beach, CA 92075 USA

Phone: (858) 925-7049

Uk Address: Mereside, Alderley Park Alderley Edge, Cheshire, SK10 4TG United Kingdom

Email: [email protected]

Website: Click Here

Apollon Formularies Plc

Website: click here

Phone: +44 20 7907 9314

Email: [email protected]

Address: 48 Warwick St, London W1B 5AW, United Kingdom


Email: [email protected]/[email protected]

Address: 480 University Ave, Suite 1502 Toronto, ON M5G 1V2 Canada

Website: Click Here

Botanix Pharmaceuticals

Email: [email protected]

Phone: +61 8 6555 2945

Address: Level 1, 50 Angove Street, North Perth WA 6006

PO Box 1407, Subiaco WA 6904

Website: Click Here


Address: #3 Bethesda Metro Center, Suite 700, Bethesda, MD, 20814, USA

Phone: (877) 424-2429

Website: Click Here

Cannabis Science

Address: 19800 MacArthur Blvd. Suite #300 Irvine, CA 92612

Email[email protected]

Tel: +1.778.288.1389

Website: Click Here

Cannablis & Co

Address: Portland, Oregon, United States

Website: Click Here

Phone Number: (503) 719-4338

Cb therapeutics

Address: 2717 Loker Ave. W. Carlsbad, CA 92010

Phone: +1.833.322.6437

Website: Click Here

Corbus Pharmaceuticals

Address: 500 River Ridge Drive Norwood, MA 02062

Phone: 617.963.0100

Email: [email protected]

Website: Click Here

Diverse Biotech

Email: [email protected]

Phone Number: +1-407-917-0897

Address: Orlando, Florida, United States

Website: Click Here

Emerald Pharmaceuticals

Address: 5910 Pacific Center Blvd., #320 San Diego, CA, 92121

Phone: 1.858.352.0622

Website: Click Here

Enveric Biosciences

Address: 4851 Tamiami Trail N, Suite 200 Naples, FL 34103

Email: [email protected]

Website: Click Here

FSD Pharma

Website: click here

Email: [email protected]

Address: 199 Bay St.Suite 4000 Toronto, ON, M5L 1A9 Canada


Phone: 1 833- 4 3 6 2 2 6 6

Email: [email protected]

Address: 320 East Vine Drive, Suite 207 Fort Collins, CO 80524 the USA

Website: Click Here

GW Pharmaceuticals

Address: Waterloo Exchange, Waterloo Road, Dublin 4

V.A.T. Registration number: 6419192A

Phone: +353.1.634.7800

Email: [email protected]

Website: Click Here

Inmed Pharmaceuticals

Phone: 1 (604) 669-7207

Fax: 1 (778) 945-6800

Address: #310-815 West Hastings St., Vancouver BC, V6C 1B4

Website: Click Here

Instadose Pharma Corp.

Address: 5500 N Service Rd Suite 301, Burlington, ON L7L 6W6, Canada

Website: Click Here

Phone: +1 905-218-3593

Email: [email protected]

MAK Scientific LLC

Address: 151 South Bedford Street, Mail Box #3 Burlington, MA 01803

Phone: 1-781-365-0958

Email[email protected]

Website: Click Here

Medipure Pharmaceuticals

Address: 302-267 West Esplanade Ave North Vancouver, BC V7M 1A5

Phone: (877) 264-0345

Fax: (877) 264-0345

Email: [email protected]

Website: Click Here

MyMD Pharmaceuticals

Email: [email protected]

Address: 855 N Wolfe St, Ste 623 Baltimore, Maryland 21205

Phone: (813) 864-2566

Website: Click Here


Address: 3805 Old Easton Road Doylestown, PA 18902

Website: Click Here

Tel: (215) 695-6559

Fax: (516) 960-9212

Email: [email protected]

Nexien Biopharma

Email: [email protected]

Website: Click Here


Telephone Number: 929 352-4009

Fax Number: 647 4994292

OWC pharmaceuticals

Address: Ramat Gan, Tel Aviv, Israel

Website: Click Here

Email: [email protected]

Phone Number: +972 (0)722608004

Panag Pharma

Address: Halifax, Nova Scotia, Canada

Website: Click Here

Email: [email protected]

Pascal Biosciences

Phone: 206.221.3443

Email: [email protected]

Address: Fluke Hall, Suite 304 Box 352141 4000 Mason Road Seattle, WA 98195-2141

Website: Click Here

Realize Therapeutics

Address: 37 Sherwood Terrace Suite 110 Lake Bluff, Illinois 60044

Phone: 847-582-1300

Website: Click Here

Receptor Life Sciences

Address: P.O. Box 99764 Seattle, WA 98139-0764

Email: [email protected]

Website: Click Here

Renew BioPharma

Email: [email protected]

Address: San Diego, California, United States

Website: Click Here

Respire RX

Address: Glen Rock, New Jersey, United States

Website: Click Here

Email: [email protected]

Phone Number: (917) 834-7206

Revive Therapeutics

Address: 82 Richmond Street East Toronto, Ontario M5C 1P1

Phone: +1 888 901-0036

Website: Click Here

SciCann Therapeutics

Email: [email protected]

Phone Number: +97 052 733 01424

Address: Toronto, Ontario, Canada

Website: Click Here


Phone: +972-3-7175777

E-mail: [email protected]

Address: Giv’atayim, Tel Aviv, Israel

Serina Therapeutics, Inc.

Address: 601 Genome Way Suite 2001 Huntsville, Alabama 35806

Phone: 256.327.0566

Website: Click Here

Skye Biosciences

Address: 11250 El Camino Real, Suite 100 San Diego, CA 92130

Phone: (858) 410-0266

Website: Click Here

Email: [email protected]

SOL Global

Address: Suite 5600, 100 King Street West Toronto, ON, Canada M5X 1C9

Website: Click Here

Phone Number: (+1) 212 729-9208

Syqe Pharmaceuticals

Email: [email protected]

Fax: +972-73-780-3674

Address: Tel Aviv, Tel Aviv, Israel

Website: Click Here

Phone Number: +972 3-560-1097

Tetra Bio-Pharma

Phone: 1 (833) 977-7575 (toll-free)/1 (438) 899-7575 (Quebec)/1 (343) 780 2020 (Ontario)

Address: 2316 St-Joseph Blvd. Orleans, ON Canada K1C 1E8

Website: Click Here

Vivera Pharmaceuticals

Phone: 1-844-484-8372

Email: [email protected]

Website: Click Here


Zynerba Pharmaceuticals

Address: 80 W. Lancaster Avenue Suite 300 Devon, PA 19333

Phone: 484.581.7505

Website: Click Here

Frequently Asked Questions

What exactly are cannabinoids in pharmaceuticals?

Cannabinoids derived from the cannabis plant, such as 9-tetrahydrocannabinol (THC), cannabidiol (CBD), or a combination of THC and CBD, are present in cannabis-based medicinal products. Synthetic cannabinoids used for medical purposes typically mimic the effects of specific cannabinoids such as THC.

What exactly is CBD in pharmaceuticals?

Cannabidiol (CBD) is a chemical found in the Cannabis sativa plant, also known as hemp or cannabis.

In the United States, one type of CBD is approved as a seizure medication. The Cannabis sativa plant contains over 80 chemicals known as cannabinoids.

What is the rarest cannabinoid?

Rare cannabinoids such as cannabigerol (CBG), cannabinol (CBN), and tetrahydrocannabivarin (THCV) are thought to have more beneficial medical properties than THC and CBD while containing none of THC’s psychoactive properties.

How many cannabinoids have been discovered?

What is the total number of cannabinoids? In addition to THC and CBD, over 100 other cannabinoids have been identified.


The impending union of the biotech industry and the legal (i.e. medical) cannabis industry appears to be a long and happy one.

As the use of legal marijuana grows around the world, medicinal (rather than recreational) revenues will grow and become the dominant share of the legal marijuana market.

The global legal marijuana market is expected to reach USD 73.6 billion by 2027, according to Grand View Research.

During the forecast period, it is expected to grow at a CAGR of 18.1 percent. Increased legalization of cannabis for medical (as well as recreational) use is expected to spur growth.

The medical segment held the leading revenue share of 71.0 percent in 2019 due to the growing acceptance of cannabis as a pharmaceutical product for treating severe medical conditions such as cancer, arthritis, Parkinson’s disease, and Alzheimer’s disease, among other neurological conditions.

Furthermore, the growing need for pain management therapies, as well as the growing disease burden of chronic pain among the elderly, are expected to drive product demand.


Leave a Reply